Medical Encyclopedia
Medicine administration through the gastrointestinal tract (oral, sublingual, rectal routes).
Also known as: Oral route, GI tract administration, PO administration
The enteral route refers to any method of medicine administration that uses the gastrointestinal tract - the mouth, esophagus, stomach, small intestine, large intestine, and rectum. It encompasses oral, sublingual, buccal, gastric (via feeding tube), and rectal administration. The term distinguishes these routes from parenteral routes (intravenous, intramuscular, subcutaneous), which bypass the GI tract entirely.
Oral administration is the most common enteral route - convenient, inexpensive, generally safe, and well-accepted by patients. Tablets, capsules, suspensions, and solutions are swallowed and absorbed primarily in the small intestine. Oral absorption is influenced by gastric emptying, intestinal motility, food, pH, and first-pass hepatic metabolism. Some medicines are formulated as enteric-coated to dissolve only in the alkaline small intestine, protecting either the stomach (aspirin) or the medicine from gastric acid (omeprazole, esomeprazole).
Sublingual and buccal administration place the medicine under the tongue or against the cheek. Medicines absorb directly through the oral mucosa into systemic veins, bypassing first-pass hepatic metabolism. This route is fast-acting and useful for medicines that would be extensively metabolized by the liver - sublingual nitroglycerin for angina relief, sublingual buprenorphine/naloxone for opioid use disorder, sublingual ondansetron orally disintegrating tablets for nausea. The medicine must be small, lipid-soluble, and not bitter to tolerate this route.
Gastric or jejunal administration via feeding tubes is used in patients who cannot swallow safely - those with stroke, dementia, head and neck cancer, or critical illness. Many oral medications can be given this way, but compatibility must be considered. Extended-release products cannot usually be crushed; enteric-coated tablets lose their coating and may irritate the stomach or be deactivated; some medicines bind to enteral feeding formulas (phenytoin, fluoroquinolones, levothyroxine), requiring tube flushing and dosing separation.
Rectal administration via suppository or enema is useful in patients who cannot tolerate oral medications - those with severe nausea, vomiting, postoperative ileus, or unconsciousness. Many medicines are available rectally: acetaminophen, ondansetron, diazepam, prednisolone enemas for ulcerative colitis. Absorption is sometimes erratic, but the lower rectal veins drain partly into systemic circulation without first-pass metabolism.
A common misconception is that enteral and parenteral are interchangeable at the same dose. They are not - oral bioavailability is almost always lower than parenteral, so doses must be adjusted when switching. Another misconception is that all oral medicines are absorbed in the stomach. Most are absorbed in the small intestine, which is why gastric emptying speed dominates oral absorption kinetics.
Prescribers consider the enteral route's advantages (convenience, cost) and limitations (slower onset, first-pass metabolism, GI side effects, food interactions) when choosing therapy.
The enteral route is the default for most outpatient prescribing. Sublingual, buccal, and rectal alternatives are valuable when oral administration is not feasible (vomiting, dysphagia, postoperative ileus, critical illness with feeding tube). Tube feeding adds complexity around medicine-food interactions and crushed-tablet compatibility.